A Proof-of-Concept Study of Faricimab (RO6867461) in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
Clinical trial NCT02484690 · COMPLETED
Trial details
- NCT number
- NCT02484690
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-11
- Primary completion
- 2017-09-26
- Enrollment
- 273
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.